Jiling Feng, PhD

Jiling Feng obtained her Ph.D. in Pharmacology from Shanghai University of Traditional Chinese Medicine in 2020. She then completed her postdoctoral training at Shuguang Hospital during from 2020 to 2022. Since 2022, she has been affiliated with Shengli's lab as a research associate. Dr. Feng's research is focused on the bioactivity and mechanisms of natural products, with a particular emphasis on the anticancer effects of small molecules associated with autophagy. At Shengli's lab, she is also engaged in the discovery of neoantigens derived from noncoding RNAs.